共 137 条
[1]
Lowenfels AB(2004)Epidemiology and prevention of pancreatic cancer Jpn J Clin Oncol 34 238-44
[2]
Maisonneuve P(2003)Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death Oncogene 22 3243-51
[3]
Arlt A(2004)Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis Cancer 101 2351-62
[4]
Gehrz A(2008)Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine J Pharmacol Exp Ther 325 484-90
[5]
Muerkoster S(2007)Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells Blood 110 735-42
[6]
Vorndamm J(2005)Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells Cancer Res 65 2076-81
[7]
Kruse ML(2005)The role of aspirin-triggered lipoxins in the mechanism of action of aspirin Prostaglandins Leukot Essent Fatty Acids 73 203-10
[8]
Folsch UR(2003)Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin Mol Cancer Ther 2 509-16
[9]
Li L(2005)Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin Cancer 103 2485-90
[10]
Aggarwal BB(2007)K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment Cancer Sci 98 1128-36